Facebook Linkedin Twitter
Inside Precision Medicine Real-World Data Reassure Advanced NSCLC Patients Stopping Immunotherapy at Two years

Treatment outcome

Real-World Data Reassure Advanced NSCLC Patients Stopping Immunotherapy at Two years
News & Features

Real-World Data Reassure Advanced NSCLC Patients Stopping Immunotherapy at Two years

Kathy Vuksanaj -
0
SEngine uses 3D cancer cell organoids grown from patient tumor samples to test more than a hundred drugs at once for efficacy against each patient's unique cancer. Source: SEngine
News & Features

Improved Bioprinted Tumor Organoids Help Predict Treatment Response

Sophia Ktori -
0
Abstract glowing virtual neural network to represent the use of AI (artificial intelligence) in personalized medicine
Informatics

AI Program Can Predict Future Health Outcomes for Patients

Helen Albert -
0
Micrograph of Renal Cell Carcinoma (RCC)
News & Features

Microscopy Findings Plus PBRM1 Status Predict Kidney Cancer Immunotherapy Response

Chris Anderson -
0
Prostate cancer
News & Features

More Men With Prostate Cancer are Opting For Active Surveillance

Chris Anderson -
0
Holographic Display of Advance DNA Sequence Analysis
Informatics

No Scientist (or Experiment) Left Behind: A Multi-Modal Informatics Case Study

Christina Jackson -
0
Image illustrating man with cardiovascular disease
News & Features

Heart Disease Risk Elevated but Modifiable in Young Cancer Survivors

Chris Anderson -
0
Liver cancer, artwork
News & Features

Robotic Liver Resection Safe Alternative to Open Surgery in HCC

Chris Anderson -
0
Brain and brain waves in epilepsy, illustration
Molecular Dx

Genetic Testing Helps Improve Outcomes in Epilepsy Patients

Helen Albert -
0
Liver cancer, illustration
News & Features

Shrinking Liver Tumors Before Transplant Greatly Improves Outcomes in HCC

Chris Anderson -
0
12345Page 3 of 5

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine